Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Zicam Products
Case Name (Date)
Yamasaki et al v. Zicam LLC and Matrixx Initiatives, Inc.
21-cv-2596, N.D. Cal.
(June 2021)
Product/Service
Zicam Original RapidMelts, Zicam ULTRA RapidMelts, Zicam Elderberry Citrus RapidMelts, Zicam Nasal Swabs, Zicam Nasal Spray, Zicam Wild Cherry Lozenges, and Zicam Oral Mist
Allegations
Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
Status
Dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.
Class-Action Tracker
Zicam Pre-Cold Remedies
Zicam Pre-Cold Medicine Products
The Latest
Ad Council: The Secret to Motherhood
Recent ad encourages mothers to prioritize their mental health.
HydroJug’s Heat-Retention Claims
Can these bottles really keep drinks hot for up to six hours?
With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Bytech America’s Made in USA Claims
Marketing and reality are not in sync.